Ischemic Stroke Outcomes and Comorbidity Assessment

Ischemic stroke remains a leading cause of mortality and long‐term disability worldwide, with outcomes determined by the interplay of acute neurological injury and pre‐existing health conditions. Assessment of initial severity using standardised scales guides treatment decisions, while functional measures track recovery and inform rehabilitation. Comorbidity assessment has emerged as a critical dimension in prognostication, trial design and health‐system planning. Tools such as the Charlson Comorbidity Index quantify the burden of chronic diseases, enabling case‐mix adjustment and risk stratification. Multimorbidity influences both short‐term stroke severity and long‐term survival, often interacting with premorbid disability and vascular risk factors. Recent advances have explored novel predictors—from muscle mass measures to machine‐learning proxies for stroke severity—broadening the scope of risk modelling. Precision in comorbidity quantification supports tailored interventions, enhances external validity of trials and underpins equitable allocation of acute therapies such as intravenous thrombolysis or endovascular thrombectomy. As populations age and chronic disease prevalence rises, integrating comorbidity profiles with imaging and clinical scales will be pivotal for optimising individual outcomes and guiding policy on stroke care resources.

Research from Nature Portfolio

A large retrospective analysis investigated the impact of muscle mass deficit on acute ischaemic stroke severity and discharge outcomes. Using bioelectrical impedance in over 650 patients, researchers demonstrated that reduced skeletal muscle mass was independently associated with higher National Institutes of Health Stroke Scale scores at admission and with unfavourable functional status at discharge. Mediation analysis indicated that the adverse impact of muscle mass deficit on outcome operates primarily through its effect on initial neurological impairment. These findings underscore the value of body composition measures as modifiable risk factors and potential targets for pre‐stroke conditioning programmes.

Ischemic Stroke Outcomes and Comorbidity Assessment publication trend

The graph below shows the total number of articles in ischemic stroke outcomes and comorbidity assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Ischemic stroke: Brain infarction caused by obstruction of a cerebral artery, leading to neuronal injury.

National Institutes of Health Stroke Scale (NIHSS): A structured 15‐item assessment quantifying acute neurological deficits in stroke.

Modified Rankin Scale (mRS): A 7‐point scale measuring global disability or dependence in daily activities after stroke.

Charlson Comorbidity Index (CCI): A weighted scoring system that predicts mortality by assigning points for selected chronic conditions.

Multimorbidity: The coexistence of two or more chronic diseases or conditions in one individual.

Endovascular thrombectomy (EVT): A catheter‐based mechanical procedure to remove a clot from a large cerebral vessel in acute stroke.

References

1. Initial stroke severity and discharge outcome in patients with muscle mass deficit. Scientific Reports (2024).
2. Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability. International Journal of Stroke (2023).
3. Associations of Multimorbidity With Stroke Severity, Subtype, Premorbid Disability, and Early Mortality. Neurology (2023).
4. Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke. International Journal of Environmental Research and Public Health (2018).
5. Assessing stroke severity using electronic health record data: a machine learning approach. BMC Medical Informatics and Decision Making (2020).